Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome - PubMed (original) (raw)
. 2015 Jan 15;160(1-2):62-73.
doi: 10.1016/j.cell.2014.11.047.
Affiliations
- PMID: 25594175
- DOI: 10.1016/j.cell.2014.11.047
Free article
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Yiqing Yan et al. Cell. 2015.
Free article
Abstract
Inflammasomes are involved in diverse inflammatory diseases, so the activation of inflammasomes needs to be tightly controlled to prevent excessive inflammation. However, the endogenous regulatory mechanisms of inflammasome activation are still unclear. Here, we report that the neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation via the E3 ubiquitin ligase MARCH7. Importantly, in vivo data show that DA and DRD1 signaling prevent NLRP3 inflammasome-dependent inflammation, including neurotoxin-induced neuroinflammation, LPS-induced systemic inflammation, and monosodium urate crystal (MSU)-induced peritoneal inflammation. Taken together, our results reveal an endogenous mechanism of inflammasome regulation and suggest DRD1 as a potential target for the treatment of NLRP3 inflammasome-driven diseases.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
- Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Liu J, Jin Y, Wang B, Wang Y, Zuo S, Zhang J. Liu J, et al. Biochem Biophys Res Commun. 2021 Jul 5;561:7-13. doi: 10.1016/j.bbrc.2021.04.098. Epub 2021 May 13. Biochem Biophys Res Commun. 2021. PMID: 33992835 - Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
Hu Y, Mao K, Zeng Y, Chen S, Tao Z, Yang C, Sun S, Wu X, Meng G, Sun B. Hu Y, et al. J Immunol. 2010 Dec 15;185(12):7699-705. doi: 10.4049/jimmunol.1001099. Epub 2010 Nov 3. J Immunol. 2010. PMID: 21048113 - The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells.
Licandro G, Ling Khor H, Beretta O, Lai J, Derks H, Laudisi F, Conforti-Andreoni C, Liang Qian H, Teng GG, Ricciardi-Castagnoli P, Mortellaro A. Licandro G, et al. Eur J Immunol. 2013 Aug;43(8):2126-37. doi: 10.1002/eji.201242918. Epub 2013 May 24. Eur J Immunol. 2013. PMID: 23619996 - Mitochondria: Sovereign of inflammation?
Tschopp J. Tschopp J. Eur J Immunol. 2011 May;41(5):1196-202. doi: 10.1002/eji.201141436. Eur J Immunol. 2011. PMID: 21469137 Review. - Molecular mechanisms regulating NLRP3 inflammasome activation.
Jo EK, Kim JK, Shin DM, Sasakawa C. Jo EK, et al. Cell Mol Immunol. 2016 Mar;13(2):148-59. doi: 10.1038/cmi.2015.95. Epub 2015 Nov 9. Cell Mol Immunol. 2016. PMID: 26549800 Free PMC article. Review.
Cited by
- Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35.
Sun T, Xie R, He H, Xie Q, Zhao X, Kang G, Cheng C, Yin W, Cong J, Li J, Wang X. Sun T, et al. Front Immunol. 2022 Oct 13;13:1019365. doi: 10.3389/fimmu.2022.1019365. eCollection 2022. Front Immunol. 2022. PMID: 36311752 Free PMC article. - Papaverine Exerts Neuroprotective Effect by Inhibiting NLRP3 Inflammasome Activation in an MPTP-Induced Microglial Priming Mouse Model Challenged with LPS.
Leem YH, Park JS, Park JE, Kim DY, Kim HS. Leem YH, et al. Biomol Ther (Seoul). 2021 May 1;29(3):295-302. doi: 10.4062/biomolther.2021.039. Biomol Ther (Seoul). 2021. PMID: 33911050 Free PMC article. - Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI.
Bone NB, Liu Z, Pittet JF, Zmijewski JW. Bone NB, et al. J Leukoc Biol. 2017 Feb;101(2):357-365. doi: 10.1189/jlb.3HI0216-068RR. Epub 2016 Oct 12. J Leukoc Biol. 2017. PMID: 27733575 Free PMC article. - Reining in uncontrolled inflammasome with PKA.
Swanson KV, Ting JP. Swanson KV, et al. Nat Immunol. 2016 Sep 20;17(10):1137-8. doi: 10.1038/ni.3556. Nat Immunol. 2016. PMID: 27648539 No abstract available. - Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer.
Tan Y, Sun R, Liu L, Yang D, Xiang Q, Li L, Tang J, Qiu Z, Peng W, Wang Y, Ye L, Ren G, Xiang T. Tan Y, et al. Theranostics. 2021 Mar 5;11(11):5214-5231. doi: 10.7150/thno.58322. eCollection 2021. Theranostics. 2021. PMID: 33859743 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases